Improving Patient Centricity and Research Access
A clinical research trial can only be as strong its participant population, but it’s...
FEATURED E-BOOK
Making Good Clinical Practice More Understandable
This eBook dives into GCP’s role in the clinical research ecosystem and how it protects participant rights, safety, and confidentiality.
For FDA Inspection Readiness, Accountability is Key
Dawn Wydner, former Food and Drug Administration (FDA) Consumer Safety Officer, LCDR, and current...
Top 10 Educational Resources of 2021
The year 2021 brought many advancements in the clinical research industry. We’ve pushed for...
Q&A: FDA Updates: BIMO – What Sponsors Need to Know
Advarra experts Joan Versaggi and Leslie Paul answer questions from the first in the...
The Key to Increasing Diversity in Decentralized Trials
Historically, decentralized clinical trials (DCTs) were heralded as the future of patient-centered research. But...
Unique Ethical Issues in Phase I Oncology Studies
Phase I oncology trials present distinct ethical challenges, such as participant vulnerability and the...
Returning to In-person Work: Sponsor Versus Site Viewpoints
As March 2020 completely disrupted any sense of normalcy, including in the workplace, many...
Increasing Diversity, Equity, and Access in Clinical Research: A Case Study
In the evolving landscape of clinical research, increasing diversity, equity, and access has...
Effectively Working with a Research Technology Vendor During Implementation
As a research site starts the adoption and implementation process for a new technology,...
Looking for More?
To register for upcoming webinars and see where we’ll be next, go to the Events page.
Want to see the latest news and updates about Advarra? You can find them in the Newsroom.
